Call for Abstract

International Conference on Antimicrobial and Antibacterial Agents, will be organized around the theme “ Amelioration in Research to Retried Antimicrobial Agents”

Antimicrobial Congress 2018 is comprised of 18 tracks and 45 sessions designed to offer comprehensive sessions that address current issues in Antimicrobial Congress 2018.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

Antibacterial therapy contain an accurate diagnosis of infection, understanding the difference between empiric & definitive therapy, cost effective oral agents for the shortest duration, accounting for the host charterstics that influence antimicrobial activity, recognizing the adverse effects of antimicrobial agents on the host body. An antiseptic is used in  living tissues and cells to destroy the  infections which may be living on the tissues. Disinfectant is mean to destroy micro-organisms which can be infect nonliving objects.


  • Track 1-1Procalcitonin as a diagnostic marker of bacterial infection
  • Track 1-2Nosocomial infection
  • Track 1-3Antiphrastic drugs
  • Track 1-4Antiseptics And Germicides
  • Track 1-5Antibiotic prophylaxis

The first bacterial genome sequencing was done on 1995 which was take a new era in the field of antimicrobial drug discovers, and it is now the great tools to search whole genome for new antibacterial targets. Biofilms are medically important to accounting for over 80% of microbial infections in the body. Drug resistance  bacteria lead to poor clinical outcomes increasing health care cost and mortality.


  • Track 2-1Nanotechnology based antibacterial therapy
  • Track 2-2Drug toxicity
  • Track 2-3Gut flora
  • Track 2-4Biofilm resistance to antibacterial agents
  • Track 2-5R-Plasmid-mediated resistance

Antimicrobial chemotherapy is a clinical approach of antimicrobial agents to treat infectious disease. There are chemotherapy treatments for bacterial infection, fungal infection, protozoan infections, warm infectious and viral infections. Antimicrobial agents that treat microorganism infections area unit given as medication therapy, equally for plant life, microorganism and protozoan infections area unit they're given as antifungal, antiviral and medication therapy.


  • Track 3-1Antibacterial agents
  • Track 3-2Antifungal agents
  • Track 3-3Chemotherapeutic agents
  • Track 3-4Anthelminthic agents

It is an analysis of the antibacterial clinical development pipeline, including mycobacterium tuberculosis. Resistance is a natural phenomenon which will develop by time. As misuse and overuse of antibiotics at accelerate the development of resistance. Antibiotics should be used for antibacterial treatment. The lack of new quality lead chemicals to test against gram-ve bacteria is another major impediment to discovery.


  • Track 4-1Phytotherapy
  • Track 4-2Vaccines against human papillomavirus
  • Track 4-3Ethnopharmacology

The pharmacology of antimicrobial agents are the drugs which is used in the treatment of bacterial infections. Β-lactams are a well established group of antibiotics that include penicillin, cephalosporines, carbapenems and monobactams.


  • Track 5-1Clindamycin as an antibiotic
  • Track 5-2Macrolides: antibiotic or antifungal agents
  • Track 5-3Cephalosporins as bactericidal
  • Track 5-4A spectrophotometric assay of β-lactamase action on penicillin’s

Vaccines can reduce the prevalence of resistance by reducing the need for antimicrobial use and can reduce its impact by reducing the total number of cases. By reducing the number of pathogens that may be responsible for a particular clinical syndrome, vaccines can permit the use of narrower-spectrum antibiotics for empirical therapy. These effects may be amplified by herd immunity, extending protection to unvaccinated persons in the population. Because much selection for resistance is due to selection on bystander members of the normal flora, vaccination can reduce pressure for resistance even in pathogens not included in the vaccine. Some vaccines have had disproportionate effects on drug-resistant lineages within the target species, a benefit that could be more deliberately exploited in vaccine design.


  • Track 6-1Hib conjugate vaccine
  • Track 6-2Respiratory virus vaccine

Based on drug class, the global antibacterial drugs market is classified into B – lactams, quinolones, macrolides, tetracycline, aminoglycoside, sulfonamide, phenicol’s, and others. In terms of routes of administration, the global antibacterial drugs market has been segmented into enteral, parenteral and others. Likewise, the global antibacterial drugs market has been further segmented into hospital pharmacies, drug stores and retail pharmacies and online sales, in terms of distribution channel. Analyst predicts that the global antibacterial drugs market to gain significantly from the increasing incidence of infectious diseases.


  • Track 7-1CAPEX cycle

The global antimicrobial textiles market based on agent, application, finishing technique, and region. To forecast the market size, in terms of value and volume, of five main regional markets, namely, Asia-Pacific, Europe, North America, South America, and Middle East & Africa. It is also provide detailed information on the key factors influencing the market growth, such as drivers, restraints, opportunities, and industry-specific challenges. We can strategically analyse micro-markets with respect to individual growth trends, prospects, and contribution to the total market.


  • Track 8-1Use of zinc oxide nano particles for production of antimicrobial textiles
  • Track 8-2Develop antimicrobial textiles based on sustainable biopolymers
  • Track 8-3Inorganic sol–gel coatings in textiles
  • Track 8-4Green chemistry approach for textile

Infection as a cause of neurologic disease is a prominent feature. Nonepidemic viral infections constitute the majority of infections affecting the nervous system today.  Chronic neurologic disease as a sequel to infection is a relatively new and developing area of both pediatric and adult neurology research. Chief among these disorders is the role of post infectious brain inflammation in epileptogenic.


  • Track 9-1Toxoplasmosis
  • Track 9-2Neuroepidemiology
  • Track 9-3Neurocystercercosis
  • Track 9-4Neurovirology
  • Track 9-5Bacteria Induced Neuropathies

Sever infections represent the main cause of neonatal mortality accounting for more than one million neonatal death. Antibiotics are the common medication in neonatal intensive care unit. While there is a growing choice of agents against multi-resistant gram-positive bacteria, new options for multi-resistant gram-negative bacteria in the clinical practice have decreased significantly in the last 20 years making the treatment of infections caused by multidrug-resistant pathogens challenging mostly in neonates


  • Track 10-1Biomarkers for detection of colonic neoplasms
  • Track 10-2Molecular pathology of protest cancer
  • Track 10-3Disease nosology

Plant bacteriology involves the scientific study of bacteria identification, disease etiology, disease cycles, economic impact, epidemiology of plant diseases, plant disease resistance, the way in which plant diseases affect humans and animals. Some bacteria causes a small proportion of plant diseases, this does not mean that these diseases are unimportant. Pathogenic tests can be done for the prevention of disease.  Both natural and cultivated plants carry genetics disease resistance, but there are numerous examples of devastating plant disease.


  • Track 11-1Phytobacteriology

Antimicrobial resistance is the epidermis of emerged resistance genes  with variable linked within a verity of genetic elements which is  spread through interconnecting bacterial populations of antimicrobial exposed people, animals and places.  Epidemiology include  causation of diseases, transmission of diseases, forensic epidemiology, Occupational epidemiology, screening and the treatment effects such as in clinical trials


  • Track 12-1Cardiovascular disease
  • Track 12-2Multidrug resistance
  • Track 12-3Antimicrobial stewardship
  • Track 12-4Bloodstream infection
  • Track 12-5Molecular diagnostics

Antimicrobial oral therapy is a form of oral treatment used to eliminate or reduce the development of bacterial infections in the mouth. The therapy is prevent periodontal disease resulting from infections, which can cause painful, bleeding gums and loosening of your teeth. Antimicrobial mouth rinses are much more powerful than over the counter mouthwashes which is  reducing certain bacteria that cause gum disease to an almost undetectable level.


  • Track 13-1Antimicrobial therapy
  • Track 13-2Oral pathology therapy

Pediatric virology is deals with the viral diseases during early childhood stage or in embryo stage.  It is not an isolated discipline but the syndromes associated with viral infection are modified by the unique characteristics of infancy and childhood.  The most common viral fever in childhood stage is the seasonal flu or influenza. But children can catch milder viral. Mostly the childhood viral infections are not serious and include varieties of illnesses as colds with a sore throat, vomiting and diarrhea, and fever with a rash. But there are some viral illnesses that cause more serious disease, such as measles. That causes a disease named chickenpox which most commonly affecting children. Polio is highly infectious diseases that primarily affects children under five years of age. The most common Pediatric cancers are  leukemia , brain tumors and lymphomas .


Overuse of antibiotics cause killing sensitive bacteria but may be the growth and multiply of resistance bacteria. The rapid emergence of resistant bacteria is occurring worldwide, endangering the efficiency of antibiotics, which have transformed medicine and save millions of lives. Infectious caused by antimicrobial resistant bacteria are associated with susceptible bacteria. The emergence and spread of this bacteria is complex and requires incorporating numerous interrelated facts.


  • Track 15-1Multidrug resistance Pseudomonas Aeruginosa